23andMe plans to recruit 100,000 customers into a genetic weight loss study, the Mountain View, Calif.-based personal genomics and biotechnology company announced Dec. 28. The project will investigate ...

23andMe presented data from the now completed dose escalation phase, and pharmacokinetic / pharmacodynamic (PK/PD) cohorts at the Society for Immunotherapy of Cancer Annual Meeting 2023 Dosing with ...

First clinical results to be presented at the AACR Annual Meeting 2023 showed 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics and peripheral ...

Consumer gene testing company 23andMe is launching a large online study on the relationship between genetics and weight loss behaviors. Drawing volunteer subjects from its existing customers, the ...